STEPHEN BEHAN: Open Payments
NPI 1225751381 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 34 payments from 15 companies in 2025. Trend: 2023 $414 · 2024 $517 · 2025 $618
Food & beverage: $603Education: $15
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 4 | $82 |
| Novo Nordisk Inc | 5 | $76 |
| PFIZER INC. | 4 | $68 |
| Indivior Inc. | 3 | $67 |
| Lilly USA, LLC | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Dexcom, Inc. | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: BRIXADI, PREVNAR 20, SUBLOCADE, CAPLYTA, MOUNJARO, Ozempic, Dexcom G6 Transmitter, HETLIOZ.
Industry payments across SC — which companies pay providers there.
